It is clinically employed as an adjunct therapy in infectious diseases, cancers, and immunodeficiency conditions due to its ability to stimulate T cell maturation and modulate both innate and adaptive immune responses 1,3,4
3 Frontiers in Pharmacology (2024)NNMT as a candidate therapeutic target for metabolic syndrome (review)
Researchers observed that by blocking this enzymatic step, 5-Amino-1MQ may increase the availability of nicotinamide for conversion back to NAD+ through the salvage pathway
Clinical trials confirmed no IGF-1 elevation and no negative impact on glucose metabolism, even during 24-week treatment periods
They are not approved for human or veterinary administration, are not evaluated by the FDA or EMA, and must not be used as drugs, supplements, or cosmetic products